Intrexon Corporation News Headlines

XON 
$42.92
*  
0.73
1.73%
Get XON Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading XON now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Don't Mimic Warren Buffett - Cramer's Mad Money (2/18/15)
2/19/2015 7:35:00 AM - Seeking Alpha


Pull The Trigger On Acorda - Cramer's Lightning Round (2/18/15)
2/19/2015 6:40:00 AM - Seeking Alpha


Soligenix's SGX943 And SGX101 May Be A Solution For Melioidosis Treatment
2/18/2015 2:08:00 PM - Seeking Alpha


The Guru's Bold Call That I Can't Ignore
2/17/2015 5:00:00 AM - Investopedia


Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update
2/17/2015 3:24:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More
2/6/2015 4:00:00 PM - Seeking Alpha


Why Intrexon And Ziopharm Investors Now Face Increased Risk Both Short And Long-Term
2/3/2015 6:38:00 PM - Seeking Alpha


InsiderInsights.com Daily Round Up 1/27/15: OKSB, OAS, XON, MLNK
1/28/2015 11:20:00 AM - Seeking Alpha


Update: A Dangerous Time To Short Intrexon
1/28/2015 3:42:00 AM - Seeking Alpha


Intrexon To Buy Rest Of Exemplar Genetics
1/26/2015 1:43:00 PM - RTT News


XON Prices Offering At $27/Share
1/22/2015 3:46:00 AM - RTT News


Update: Intrexon Announces Massive Secondary, Should Investors Worry?
1/21/2015 2:41:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


ZIOPHARM, Intrexon Ink CAR T Deal with MD Anderson - Analyst Blog
1/16/2015 4:45:00 AM - Investopedia


Update: Intrexon Expands Partnership With Fibrocell Sciences
1/15/2015 2:13:00 AM - Seeking Alpha


Ziopharm up big on CAR-T license deal
1/14/2015 8:25:00 AM - Seeking Alpha


Update: Intrexon Announces Exclusive Licensing Agreement With MD Anderson
1/14/2015 12:27:00 AM - Seeking Alpha


World Bank Lowers Outlook for Global Growth
1/13/2015 4:25:00 PM - Dow Jones Business News


Intrexon Corporation Has Two Overlooked Opportunities In The Anti-Infective Space
12/29/2014 12:51:00 PM - Seeking Alpha


Cramer's Mad Money - 13 Things To Watch In The Week Ahead (12/12/14)
12/14/2014 6:42:00 AM - Seeking Alpha


Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update
11/24/2014 2:26:00 AM - Seeking Alpha


Monopoly Hunt - Why Competition Is For Losers
10/10/2014 9:22:00 PM - Seeking Alpha


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


The Antibiotic Resistance Triple Threat
9/4/2014 2:05:00 PM - Seeking Alpha